FindTrial
Sign In

Effect of artemether on human beta-defensin-2 gene expression in acne lesions

Effect of artemether on human beta-defensin-2 gene expression in acne lesions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800020035
Enrollment
Unknown
Registered
2018-12-12
Start date
2018-04-01
Completion date
Unknown
Last updated
2018-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne

Interventions

Experimental group:External application of artemether
Blank control group:none

Sponsors

Shanghai Pudong New Area Zhoupu Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Twenty patients (8th edition of People's Health Publishing House of Dermatology and Venereology) who met the clinical diagnostic criteria of acne were selected from the dermatology clinic of Zhoupu Hospital; 2. Fifteen healthy volunteers served as blank control group.

Exclusion criteria

Exclusion criteria: (1) Persons under the age of 18 or over 70 years; (2) Lactating or pregnant women; (3) Patients with serious primary diseases such as cardio-cerebrovascular, liver, kidney and hematopoietic system, connective tissue diseases such as lupus erythematosus and psychosis; (4) Occupational acne caused by chemicals or acne caused by drugs.

Design outcomes

Primary

MeasureTime frame
human beta-defensin-2 gene;—

Countries

China

Contacts

Public ContactGuojiang Wang

Department of Dermatology, Zhouyuan Hospital

zpyywang@163.com+86 13671675186

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026